Atomoxetine Sandoz 40 mg Norge - norsk - Statens legemiddelverk

atomoxetine sandoz 40 mg

sandoz - københavn - atomoksetinhydroklorid - kapsel, hard - 40 mg

Atomoxetine Sandoz 60 mg Norge - norsk - Statens legemiddelverk

atomoxetine sandoz 60 mg

sandoz - københavn - atomoksetinhydroklorid - kapsel, hard - 60 mg

Atomoxetine Sandoz 80 mg Norge - norsk - Statens legemiddelverk

atomoxetine sandoz 80 mg

sandoz - københavn - atomoksetinhydroklorid - kapsel, hard - 80 mg

Givlaari Den europeiske union - norsk - EMA (European Medicines Agency)

givlaari

alnylam netherlands b.v. - givosiran - porfyrier, nedsatt - ulike alimentary tract and metabolism products - behandling av akutt hepatisk porfyri (ahp) i voksne og ungdom i alderen 12 år og eldre.

Bemrist Breezhaler Den europeiske union - norsk - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Atectura Breezhaler Den europeiske union - norsk - EMA (European Medicines Agency)

atectura breezhaler

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Oxlumo Den europeiske union - norsk - EMA (European Medicines Agency)

oxlumo

alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - andre alimentary tract and metabolism products, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Den europeiske union - norsk - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaksiner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.

Enspryng Den europeiske union - norsk - EMA (European Medicines Agency)

enspryng

roche registration gmbh - satralizumab - neuromyelitis optica - immunsuppressive - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.

Calcipotriol/Betamethasone Aristo 50 mikrog/ g / 0.5 mg/ g Norge - norsk - Statens legemiddelverk

calcipotriol/betamethasone aristo 50 mikrog/ g / 0.5 mg/ g

aristo pharma gmbh - kalsipotriolmonohydrat / betametasondipropionat - gel - 50 mikrog/ g / 0.5 mg/ g